Healthcare Solutions Management Group Inc(HSMD)
$0.200.00 (0.00%)
HSMD
Healthcare Solutions Management Group Inc financials statements
$0.20
At close:0.00 (0.00%)
Healthcare Solutions Management Group Inc (HSMD) Ratios
6 Followers
Healthcare Solutions Management Group Inc Ratios
HSMD's free cash flow for Q4 2021 was $-5.58M. For the 2021 fiscal year, HSMD's free cash flow was decreased by $-71.87K and operating cash flow was $-5.51M. See a summary of the company’s cash flow.
| Ratios | Sep 21 | Sep 20 | Jun 19 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 6.31 | 5.87 | 15.97 |
| Quick Ratio | 6.31 | 5.86 | 15.97 |
| Cash Ratio | 0.05 | 0.06 | 0.07 |
| Solvency Ratio | -0.01 | -0.00 | 0.00 |
| Operating Cash Flow Ratio | -0.25 | -0.22 | -0.00 |
| Short-Term Operating Cash Flow Coverage | -0.25 | -0.22 | -0.00 |
| Net Current Asset Value | $ 76.83M | $ 69.73M | $ 86.66M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.16 | 0.17 | 0.06 |
| Debt-to-Equity Ratio | 0.18 | 0.20 | 0.07 |
| Debt-to-Capital Ratio | 0.16 | 0.17 | 0.06 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.18 | 1.20 | 1.07 |
| Debt Service Coverage Ratio | 0.00 | -0.00 | 0.00 |
| Interest Coverage Ratio | -19.81 | -483.84 | 0.00 |
| Debt to Market Cap | 0.51 | 0.03 | 13.44 |
| Interest Debt Per Share | 2.56 | 0.15 | 67.18 |
| Net Debt to EBITDA | 0.00 | 0.00 | 0.00 |
| Profitability Margins | |||
| Gross Profit Margin | 73.36% | 26.35% | 77.26% |
| EBIT Margin | -28.69% | -85.81% | -308.51% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -28.69% | -85.81% | -308.51% |
| Pretax Profit Margin | -30.14% | -85.98% | -308.51% |
| Net Profit Margin | -30.14% | -85.98% | -308.51% |
| Continuous Operations Profit Margin | -30.14% | 0.00% | -308.51% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 105.05% | 100.20% | 100.00% |
| Return on Assets (ROA) | -2.99% | -3.58% | -5.14% |
| Return on Equity (ROE) | -3.54% | -4.31% | -5.48% |
| Return on Capital Employed (ROCE) | -3.37% | -4.30% | -5.48% |
| Return on Invested Capital (ROIC) | -2.85% | -3.58% | -5.14% |
| Return on Tangible Assets | -2.99% | -3.58% | -5.14% |
| Earnings Yield | -9.79% | -0.66% | -1104.19% |
| Efficiency Ratios | |||
| Receivables Turnover | 11.20 | 47.22 | 0.00 |
| Payables Turnover | 110.99 | 23.75 | 776.07 |
| Inventory Turnover | 0.00 | 42.79 | 0.00 |
| Fixed Asset Turnover | 5.08 | 6.00 | 0.00 |
| Asset Turnover | 0.10 | 0.04 | 0.02 |
| Working Capital Turnover Ratio | 0.13 | 0.05 | 0.00 |
| Cash Conversion Cycle | 29.30 | 0.89 | -0.47 |
| Days of Sales Outstanding | 32.59 | 7.73 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 8.53 | 0.00 |
| Days of Payables Outstanding | 3.29 | 15.37 | 0.47 |
| Operating Cycle | 32.59 | 16.26 | 0.00 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | -0.63 | -0.03 | -0.05 |
| Free Cash Flow Per Share | -0.84 | -0.04 | -0.05 |
| Dividend Paid and CapEx Coverage Ratio | -2.90 | -5.34 | 0.00 |
| Capital Expenditure Coverage Ratio | -2.90 | -5.34 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.25 | -0.22 | -0.00 |
| Operating Cash Flow to Sales Ratio | -0.39 | -0.89 | -0.00 |
| Free Cash Flow Yield | -16.90% | -0.81% | -1.09% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -10.21 | -152.17 | -0.09 |
| Price-to-Sales (P/S) Ratio | 3.08 | 130.84 | 0.28 |
| Price-to-Book (P/B) Ratio | 0.36 | 6.56 | 0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.92 | -123.96 | -91.40 |
| Price-to-Operating Cash Flow Ratio | -7.96 | -147.19 | -91.40 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 1.52 | 0.00 |
| Enterprise Value Multiple | 0.00 | 0.00 | 0.00 |
| Enterprise Value | 42.26M | 474.42M | 5.80M |
| EV to EBITDA | 0.00 | 0.00 | 0.00 |
| EV to Sales | 4.57 | 134.63 | 3.77 |
| EV to Free Cash Flow | -8.79 | -127.55 | -1232.57 |
| EV to Operating Cash Flow | -11.82 | -151.45 | -1232.57 |
| Tangible Book Value Per Share | 13.82 | 0.76 | 1007.71 |
| Shareholders’ Equity Per Share | 13.82 | 0.76 | 1007.71 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 1.62 | 0.04 | 17.90 |
| Net Income Per Share | -0.49 | -0.03 | -55.21 |
| Tax Burden | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.05 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.38 | 0.47 | 3.86 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.28 | 1.03 | 0.99 |
Currency in USD
